The internet blew up when an Esquire video of actress Jenna Ortega circulated and people noticed a much slimmer look. Dave Rubin shared a clip from his Actual Friends podcast where co-hosts Jillian Michaels, Sage Steele and Dr. Drew used the moment to warn about GLP‑1 weight‑loss drugs such as Ozempic. The episode stoked a real debate: are these medicines helping people, or are they creating a new set of harms we barely understand?
Podcast clip amplifies fears
What the hosts said
On the Actual Friends clip, Dr. Drew warned he is “gravely concerned about the muscle loss associated with GLP‑1s,” and Jillian Michaels pushed back hard on non‑medical use of these drugs. Rubin’s repost drove more eyes to the conversation. To be clear: no one has produced proof that Jenna Ortega is taking Ozempic or any GLP‑1 medication. Her family publicly asked critics to stop speculating. But the clip illustrates how celebrity photos quickly become proof in the court of public opinion — even when the facts are thin.
The medical facts
Known risks and what studies show
GLP‑1 drugs like semaglutide (branded as Ozempic or Wegovy in certain doses) are real medicines with real benefits: they lower blood sugar and can produce large amounts of weight loss. They also carry FDA‑listed risks, including acute pancreatitis, complications of diabetic retinopathy, and gallbladder disease. Clinical trials and reviews show that when people lose a lot of weight on semaglutide, a notable portion of that loss can be lean mass, not just fat — which raises real concerns about muscle loss and frailty, especially without resistance exercise and proper protein intake.
Why this matters beyond celebrity gossip
When a movie star’s look becomes a headline, the real-world result is predictable: demand spikes, doctors come under pressure to prescribe, and social media serves as both judge and jury. That can push healthy people toward powerful drugs for cosmetic reasons and create dangerous mixed messages for people with eating disorders. Responsible coverage should note the benefits, name the known risks, and avoid declaring medication use without confirmation. Regulators and clinicians should also insist on safeguards when these drugs are prescribed off‑label or compounded.
The bottom line
We need two things at once: commonsense caution and personal responsibility. Leave celebrities alone unless they say something publicly. At the same time, stop treating weight‑loss drugs as a one‑size‑fits‑all beauty quick fix. Talk to a real doctor, check the FDA labeling, and if someone is going to lose a lot of weight, plan to protect muscle with resistance training and nutrition. The medicine can help — but only if we stop treating headlines as medical advice and start demanding honesty and care instead.

